EAGLE ASSET MANAGEMENT INC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 152 filers reported holding KURA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q1 2023$4,592,000
-6.5%
375,493
-7.9%
0.03%
-10.0%
Q4 2022$4,910,000
-50.1%
407,500
-43.5%
0.03%
-53.1%
Q3 2022$9,843,000
-27.7%
720,638
-2.9%
0.06%
-24.7%
Q2 2022$13,606,000
+9.8%
742,327
-3.7%
0.08%
+34.9%
Q1 2022$12,395,000
+17.7%
770,889
+4.5%
0.06%
+37.0%
Q4 2021$10,530,000
-29.8%
737,419
-7.9%
0.05%
-32.4%
Q3 2021$14,999,000
-10.2%
800,854
-0.0%
0.07%
-5.6%
Q2 2021$16,705,000
-32.6%
801,213
-5.2%
0.07%
-34.5%
Q1 2021$24,785,000
-3.9%
845,190
+7.0%
0.11%
-24.7%
Q4 2020$25,799,000
-43.8%
789,964
-47.5%
0.15%
-38.4%
Q3 2020$45,930,000
+38.1%
1,503,451
-25.0%
0.24%
+25.4%
Q2 2020$33,253,000
+63.3%
2,004,453
-2.1%
0.19%
+48.8%
Q1 2020$20,367,000
-28.2%
2,046,984
-0.7%
0.13%
-6.6%
Q4 2019$28,348,000
-10.0%
2,061,677
-0.7%
0.14%
-16.0%
Q3 2019$31,489,000
-21.8%
2,075,747
+1.6%
0.16%
-21.4%
Q2 2019$40,243,000
+18.4%
2,043,869
-0.2%
0.21%
+13.8%
Q1 2019$33,988,000
+19.0%
2,048,708
+0.7%
0.18%
+0.6%
Q4 2018$28,562,000
-21.2%
2,034,391
-1.7%
0.18%
+2.9%
Q3 2018$36,232,000
+45.6%
2,070,417
+51.4%
0.18%
+30.6%
Q2 2018$24,881,0001,367,1350.13%
Other shareholders
KURA ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders